1. Home
  2. BOLD vs JOB Comparison

BOLD vs JOB Comparison

Compare BOLD & JOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • JOB
  • Stock Information
  • Founded
  • BOLD 2018
  • JOB 1893
  • Country
  • BOLD United States
  • JOB United States
  • Employees
  • BOLD N/A
  • JOB N/A
  • Industry
  • BOLD
  • JOB Diversified Commercial Services
  • Sector
  • BOLD
  • JOB Consumer Discretionary
  • Exchange
  • BOLD Nasdaq
  • JOB Nasdaq
  • Market Cap
  • BOLD 24.4M
  • JOB 21.8M
  • IPO Year
  • BOLD 2024
  • JOB N/A
  • Fundamental
  • Price
  • BOLD $1.17
  • JOB $0.20
  • Analyst Decision
  • BOLD Buy
  • JOB
  • Analyst Count
  • BOLD 4
  • JOB 0
  • Target Price
  • BOLD $4.00
  • JOB N/A
  • AVG Volume (30 Days)
  • BOLD 80.0K
  • JOB 156.5K
  • Earning Date
  • BOLD 08-05-2025
  • JOB 08-13-2025
  • Dividend Yield
  • BOLD N/A
  • JOB N/A
  • EPS Growth
  • BOLD N/A
  • JOB N/A
  • EPS
  • BOLD N/A
  • JOB N/A
  • Revenue
  • BOLD N/A
  • JOB $108,752,000.00
  • Revenue This Year
  • BOLD N/A
  • JOB $43.94
  • Revenue Next Year
  • BOLD N/A
  • JOB N/A
  • P/E Ratio
  • BOLD N/A
  • JOB N/A
  • Revenue Growth
  • BOLD N/A
  • JOB N/A
  • 52 Week Low
  • BOLD $1.00
  • JOB $0.17
  • 52 Week High
  • BOLD $4.72
  • JOB $0.51
  • Technical
  • Relative Strength Index (RSI)
  • BOLD 51.81
  • JOB 38.56
  • Support Level
  • BOLD $1.09
  • JOB $0.19
  • Resistance Level
  • BOLD $1.19
  • JOB $0.21
  • Average True Range (ATR)
  • BOLD 0.05
  • JOB 0.01
  • MACD
  • BOLD -0.00
  • JOB -0.00
  • Stochastic Oscillator
  • BOLD 82.76
  • JOB 34.00

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About JOB GEE Group Inc.

GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.

Share on Social Networks: